Literature DB >> 20477934

Functional 'glial' GLYT1 glycine transporters expressed in neurons.

Luca Raiteri1, Maurizio Raiteri.   

Abstract

Glycine transporter 1 (GLYT1) and GLYT2 are the glycine transporters in CNS. While GLYT2 is largely expressed in glycinergic neurons, GLYT1 has long been considered to be exclusively present in glial cells. There is increasing evidence that significant amounts of the 'glial' transporter also exist on neurons, particularly on pre-synaptic nerve endings of glutamatergic neurons. The functions of 'neuronal GLYT1' may be manifold and are discussed in this review. Of major interest are the interactions between neuronal GLYT1 and glutamatergic receptors of the NMDA type the activity of which is modulated not only by astrocytic GLYT1 but also by neuronal GLYT1. Pathophysiological roles and therapeutic implications of neuronal GLYT1 are emerging from recent studies with genetically modified mice, particularly with animals lacking forebrain neuron-specific GLYT1 transporters. These mutant mice exhibit promnesic phenotypes reflecting enhancement of NMDA receptor function, as it occurs following administration of GLYT1 inhibitors. Inactivation of neuronal GLYT1 in the forebrain may represent an effective therapeutic intervention for the treatment of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20477934     DOI: 10.1111/j.1471-4159.2010.06802.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.

Authors:  Surendra P Singh; Vidhi Singh
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

Review 2.  Targeting glutamate synapses in schizophrenia.

Authors:  Julie R Field; Adam G Walker; P Jeffrey Conn
Journal:  Trends Mol Med       Date:  2011-09-28       Impact factor: 11.951

3.  Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex.

Authors:  Portia A Kunz; Alain C Burette; Richard J Weinberg; Benjamin D Philpot
Journal:  J Physiol       Date:  2012-09-17       Impact factor: 5.182

4.  Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord.

Authors:  Bryony L Winters; Tristan Rawling; Robert J Vandenberg; Macdonald J Christie; Rebecca F Bhola; Wendy L Imlach
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

5.  Inhibiting glycine transporter-1 facilitates cocaine-cue extinction and attenuates reacquisition of cocaine-seeking behavior.

Authors:  Bríd Á Nic Dhonnchadha; Emmanuel Pinard; Daniela Alberati; Joseph G Wettstein; Roger D Spealman; Kathleen M Kantak
Journal:  Drug Alcohol Depend       Date:  2011-10-10       Impact factor: 4.492

6.  Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?

Authors:  Alexandre Chigaev
Journal:  Front Pharmacol       Date:  2015-07-02       Impact factor: 5.810

7.  Glycine transporter-1 inhibition promotes striatal axon sprouting via NMDA receptors in dopamine neurons.

Authors:  Yvonne Schmitz; Candace Castagna; Ana Mrejeru; José E Lizardi-Ortiz; Zoe Klein; Craig W Lindsley; David Sulzer
Journal:  J Neurosci       Date:  2013-10-16       Impact factor: 6.167

8.  1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats.

Authors:  Piotr Popik; Malgorzata Holuj; Agnieszka Nikiforuk; Tomasz Kos; Ramon Trullas; Phil Skolnick
Journal:  Psychopharmacology (Berl)       Date:  2014-09-27       Impact factor: 4.530

9.  Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model.

Authors:  Amir Mohammadzadeh; Péter P Lakatos; Mihály Balogh; Ferenc Zádor; Dávid Árpád Karádi; Zoltán S Zádori; Kornél Király; Anna Rita Galambos; Szilvia Barsi; Pál Riba; Sándor Benyhe; László Köles; Tamás Tábi; Éva Szökő; Laszlo G Harsing; Mahmoud Al-Khrasani
Journal:  Int J Mol Sci       Date:  2021-03-01       Impact factor: 5.923

Review 10.  Inhibition of Glycine Re-Uptake: A Potential Approach for Treating Pain by Augmenting Glycine-Mediated Spinal Neurotransmission and Blunting Central Nociceptive Signaling.

Authors:  Christopher L Cioffi
Journal:  Biomolecules       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.